BofA Raises UnitedHealth Price Target, Maintains Buy Rating
Bank of America raised its price target on UnitedHealth Group (UNH) while maintaining a Buy rating, following a more than 10% gain in the stock over the past 30 days, bringing it close to its 52-week high.
Analysts at Bank of America (BofA) raised their price target on UnitedHealth Group Incorporated (NYSE: UNH) while reiterating a Buy rating, according to a report from Insider Monkey. The update comes after the stock gained more than 10% over the past 30 days, trading near its 52-week high.
Rating Change
BofA maintained its "Buy" rating on UnitedHealth but raised the price target. The new target was not disclosed in the original report, but the upgrade reflects a positive outlook for the company.
Analyst Rationale
The strong stock performance is attributed to positive analyst upgrades and a proposed FTC action that may benefit the healthcare sector. The company is also considered one of the stocks that could deliver significant returns over the next three years, according to the report.
Context
UnitedHealth shares have risen over 10% in the past month, outperforming the broader market. The stock is trading near its 52-week high, indicating positive momentum. Other analysts may have differing views, but the report did not provide additional details.
What to Make of It
The price target hike from BofA reflects confidence in UnitedHealth's near-term prospects, but investors should note that the rating is not a guarantee of future performance, and the stock may be subject to market volatility.
Frequently Asked Questions
Found this useful? Share it